Drugs associated with bullous pemphigoid: role of HMG-COa reductase inhibitors

被引：4
|
作者：
Papadopoulou, A. [1 ]
Zafiriou, E. [1 ]
Koukoulis, G. K. [2 ]
Roussaki-Schulze, A. V. [1 ]
机构：
[1] Univ Thessaly, Sch Hlth Sci, Dept Dermatol, Fac Med, Larisa, Greece
[2] Univ Thessaly, Sch Hlth Sci, Dept Pathol, Fac Med, Larisa, Greece
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2020年 / 34卷 / 06期
关键词：
D O I：
10.1111/jdv.16243
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E269 / E270
页数：2
相关论文
共 50 条
  • [21] HMG-CoA reductase inhibitors and myotoxicity
    Ucar, M
    Mjörndal, T
    Dahlqvist, R
    DRUG SAFETY, 2000, 22 (06) : 441 - 457
  • [22] Rhabdomyolysis and HMG-CoA reductase inhibitors
    Omar, MA
    Wilson, JP
    Cox, TS
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (09) : 1096 - 1107
  • [23] FIBRATES AND HMG-COA REDUCTASE INHIBITORS
    HUFF, MW
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1991, 145 (08) : 977 - 977
  • [24] HMG-CoA reductase inhibitors and the kidney
    Campese, VA
    Hadaya, B
    Chiu, J
    CURRENT HYPERTENSION REPORTS, 2005, 7 (05) : 337 - 342
  • [25] HMG-CoA reductase inhibitors and the kidney
    Campese, V. M.
    Park, J.
    KIDNEY INTERNATIONAL, 2007, 71 (12) : 1215 - 1222
  • [26] Allergic reactions associated with HMG-CoA reductase inhibitors.
    Knowles, SR
    Phillips, EJ
    Weber, EA
    Shear, NH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S64 - S65
  • [27] Preventing cardiovascular atherosclerosis: Role of HMG-CoA reductase inhibitors
    Gonzalez, ER
    FORMULARY, 1996, 31 (07) : 582 - +
  • [28] Role of HMG-CoA Reductase Inhibitors in Neurological DisordersProgress to Date
    Allison B. Reiss
    Elzbieta Wirkowski
    Drugs, 2007, 67 : 2111 - 2120
  • [29] The role of HMG-CoA reductase inhibitors in homozygous familial hypercholesterolemia
    Marais, AD
    Firth, JC
    Naoumova, RP
    Thompson, GR
    DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS, 1996, 10 : 181 - 186
  • [30] HMG-CoA reductase inhibitors: Role in normal and malignant cells
    Larsson, O
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1996, 22 (03) : 197 - 212
12345